BEAT - BioTelemetry, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
51.24
-0.78 (-1.50%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close52.02
Open49.16
Bid0.00 x 800
Ask0.00 x 800
Day's Range48.69 - 51.91
52 Week Range37.07 - 80.92
Volume222,294
Avg. Volume261,595
Market Cap1.742B
Beta (5Y Monthly)1.30
PE Ratio (TTM)47.89
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • GlobeNewswire

    BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results

    Exceeds ExpectationsDelivers Double Digit Revenue Growth MALVERN, Pa., Nov. 05, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused.

  • GlobeNewswire

    BioTelemetry, Inc. to Release Third Quarter 2019 Earnings Results on November 5, 2019

    MALVERN, Pa., Oct. 29, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2019 earnings on Tuesday, November 5 at 4:00 PM Eastern Time. The BioTelemetry.

  • GlobeNewswire

    BioTelemetry, Inc. Named to Fortune Magazine’s 100 Fastest-Growing Companies List

    BioTelemetry, Inc. (BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today it has been ranked 31st on Fortune Magazine’s 100 Fastest-Growing Companies list for 2019. The ranking is based on the combination of revenue growth, earnings growth and the three-year annualized total return. It applies to U.S. publicly traded companies.

  • GlobeNewswire

    BioTelemetry, Inc. Names Manish Wadhwa, M.D., F.H.R.S. Chief Medical Officer

    BioTelemetry, Inc. (BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that Manish Wadhwa, M.D., F.H.R.S. (Fellow of the Heart Rhythm Society), has been named Chief Medical Officer. Dr. Wadhwa will lead the company’s clinical strategy and operations, reporting to Joseph H. Capper, President and Chief Executive Officer. Dr. Wadhwa, co-founder of Geneva Health Solutions, joined BioTelemetry in March 2019 as part of the company’s acquisition of Geneva.

  • GlobeNewswire

    BioTelemetry, Inc. Reports Second Quarter 2019 Financial Results

    Exceeds Expectations Achieves Record Revenue and Adjusted EBITDA MALVERN, Pa., July 30, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology.

  • GlobeNewswire

    BioTelemetry, Inc. Acquires Sweden-based ADEA Medical AB and Expands International Service Offering

    BioTelemetry, Inc. (BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced that it has acquired ADEA Medical AB, an early-stage Swedish medical technology company that delivers remote health services in the Nordics. The acquisition is aligned with BioTelemetry’s longer-term strategy to increase its international footprint and offer its products and services to physicians and patients in the Nordics and other parts of Europe. BioTelemetry advances health by providing technology and services that enable healthcare providers to monitor and diagnose patients and clinical research subjects in a more efficient, accurate and cost-effective manner.

  • GlobeNewswire

    BioTelemetry, Inc. to Release Second Quarter 2019 Earnings Results on July 30, 2019

    MALVERN, Pa., July 19, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2019 earnings on Tuesday, July 30 at 4:00 PM Eastern Time. The BioTelemetry.

  • GlobeNewswire

    Itamar Medical and BioTel Heart, a Division of BioTelemetry, Expand Collaboration to Offer Itamar’s Total Sleep Solution™ to BioTel Heart Cardiology Customers

    Itamar Medical Ltd. (NASDAQ and TASE:ITMR), a company that develops, manufacturers and markets non-invasive diagnostic devices for sleep apnea with a focus on the cardiology market, and BioTel Heart, a division of BioTelemetry, Inc. (BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced an expanded collaboration to make Itamar Medical’s Total Sleep Solution available to select BioTel Heart cardiology customers in the United States. The collaboration is designed to respond to the growing demand for home sleep apnea testing among cardiologists, who recognize effective sleep apnea management as a critical strategy for improving health in patients with cardiac disease.

  • GlobeNewswire

    BioTelemetry President and CEO Joseph H. Capper Named Healthcare CEO of the Year at 26th Annual PACT Enterprise Awards

    BioTelemetry (BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced that Joseph H. Capper, President and CEO, has been awarded the 2019 Healthcare CEO of the Year Award by the Philadelphia Alliance for Capital and Technologies, or PACT. The Healthcare CEO of the Year Award recognizes leaders for their management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company. “Each day we work with our customers and business partners to make a difference in the lives of our patients and communities,” said Joseph H. Capper, President and CEO of BioTelemetry.

  • GlobeNewswire

    BioTelemetry, Inc. Reports First Quarter 2019 Financial Results

    Achieves Record Quarterly Revenue Raises Full Year 2019 Guidance MALVERN, Pa., April 25, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology.

  • GlobeNewswire

    BioTelemetry, Inc. to Release First Quarter 2019 Earnings Results on April 25, 2019

    MALVERN, Pa., April 18, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2019 earnings on Thursday, April 25 at 4:00 PM Eastern Time. The BioTelemetry.

  • GlobeNewswire

    BioTelemetry, Inc. Elects Laura Dietch and Tiffany Olson to its Board of Directors

    BioTelemetry, Inc. (BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the election of Laura Dietch and Tiffany Olson to BioTelemetry’s Board of Directors. Ms. Dietch has more than twenty-five years of experience in the medical device industry as a Chief Executive Officer, company co-founder, director, fundraiser, inventor, and mentor. Ms. Dietch has gained extensive executive and operating experience in both private and public companies, having been a member of the senior management team in several start-up and Fortune 500 companies, including Progressive Angioplasty Systems, LuMend and Medtronic.

  • GlobeNewswire

    BioTelemetry, Inc. Reports Fourth Quarter 2018 Financial Results

    MALVERN, Pa., Feb. 21, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality.

  • GlobeNewswire

    BioTelemetry, Inc. to Release Fourth Quarter 2018 Earnings Results on February 21, 2019

    MALVERN, Pa., Feb. 11, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2018 earnings on Thursday, February 21 at 4:00 PM Eastern Time. The.

  • GlobeNewswire

    Investor Expectations to Drive Momentum within Dollar General, Zayo Group, Cabot Oil & Gas, Sangamo Therapeutics, BioTelemetry, and Dean Foods — Discovering Underlying Factors of Influence

    NEW YORK, Jan. 29, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • GlobeNewswire

    BioTelemetry, Inc. to Acquire Geneva Healthcare, Inc.

    BioTelemetry, Inc. (BEAT), the leading remote and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and Geneva Healthcare, Inc. (“Geneva”), the leading provider of remote monitoring for implantable cardiac devices are pleased to announce that the companies have entered into a definitive merger agreement whereby BioTelemetry will acquire Geneva. An early stage company, Geneva has developed a proprietary cloud-based platform that aggregates data from the leading device manufacturer systems, enabling the company to remotely monitor all of a physician’s patients with implantable cardiac devices such as pacemakers, defibrillators and loop recorders.